nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP1A2—Anagrelide—hematologic cancer	0.0388	0.0675	CbGbCtD
Ropivacaine—CYP2B6—Thiotepa—hematologic cancer	0.038	0.0661	CbGbCtD
Ropivacaine—CYP2B6—Ifosfamide—hematologic cancer	0.0215	0.0375	CbGbCtD
Ropivacaine—CYP2D6—Lomustine—hematologic cancer	0.0206	0.0358	CbGbCtD
Ropivacaine—CYP1A2—Carmustine—hematologic cancer	0.0204	0.0354	CbGbCtD
Ropivacaine—CYP2B6—Nilotinib—hematologic cancer	0.0187	0.0325	CbGbCtD
Ropivacaine—CYP2D6—Idarubicin—hematologic cancer	0.0183	0.0319	CbGbCtD
Ropivacaine—CYP1A2—Methoxsalen—hematologic cancer	0.0173	0.0301	CbGbCtD
Ropivacaine—CYP1A2—Bortezomib—hematologic cancer	0.0165	0.0287	CbGbCtD
Ropivacaine—CYP1A2—Daunorubicin—hematologic cancer	0.0158	0.0274	CbGbCtD
Ropivacaine—CYP2D6—Hydroxyurea—hematologic cancer	0.0156	0.0271	CbGbCtD
Ropivacaine—CYP1A2—Alitretinoin—hematologic cancer	0.0154	0.0269	CbGbCtD
Ropivacaine—CYP1A2—Thalidomide—hematologic cancer	0.0143	0.025	CbGbCtD
Ropivacaine—CYP3A4—Bexarotene—hematologic cancer	0.0141	0.0245	CbGbCtD
Ropivacaine—CYP2D6—Bortezomib—hematologic cancer	0.0136	0.0236	CbGbCtD
Ropivacaine—CYP3A4—Busulfan—hematologic cancer	0.0131	0.0228	CbGbCtD
Ropivacaine—CYP3A4—Lomustine—hematologic cancer	0.0131	0.0228	CbGbCtD
Ropivacaine—CYP2B6—Irinotecan—hematologic cancer	0.0129	0.0224	CbGbCtD
Ropivacaine—CYP1A2—Dacarbazine—hematologic cancer	0.0123	0.0215	CbGbCtD
Ropivacaine—CYP1A2—Imatinib—hematologic cancer	0.0121	0.021	CbGbCtD
Ropivacaine—CYP3A4—Thiotepa—hematologic cancer	0.0117	0.0203	CbGbCtD
Ropivacaine—CYP2B6—Cisplatin—hematologic cancer	0.0105	0.0182	CbGbCtD
Ropivacaine—CYP2D6—Imatinib—hematologic cancer	0.00994	0.0173	CbGbCtD
Ropivacaine—CYP1A2—Dasatinib—hematologic cancer	0.00969	0.0169	CbGbCtD
Ropivacaine—CYP3A4—Methoxsalen—hematologic cancer	0.00907	0.0158	CbGbCtD
Ropivacaine—CYP2D6—Nilotinib—hematologic cancer	0.00903	0.0157	CbGbCtD
Ropivacaine—CYP2D6—Vinorelbine—hematologic cancer	0.00896	0.0156	CbGbCtD
Ropivacaine—CYP3A4—Bortezomib—hematologic cancer	0.00863	0.015	CbGbCtD
Ropivacaine—CYP2B6—Dexamethasone—hematologic cancer	0.00846	0.0147	CbGbCtD
Ropivacaine—CYP3A4—Daunorubicin—hematologic cancer	0.00825	0.0144	CbGbCtD
Ropivacaine—CYP3A4—Cytarabine—hematologic cancer	0.00728	0.0127	CbGbCtD
Ropivacaine—CYP3A4—Teniposide—hematologic cancer	0.00717	0.0125	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—hematologic cancer	0.00702	0.0122	CbGbCtD
Ropivacaine—CYP3A4—Ifosfamide—hematologic cancer	0.00662	0.0115	CbGbCtD
Ropivacaine—CYP3A4—Imatinib—hematologic cancer	0.00632	0.011	CbGbCtD
Ropivacaine—CYP1A2—Etoposide—hematologic cancer	0.00604	0.0105	CbGbCtD
Ropivacaine—CYP3A4—Ruxolitinib—hematologic cancer	0.00595	0.0104	CbGbCtD
Ropivacaine—CYP3A4—Nilotinib—hematologic cancer	0.00574	0.01	CbGbCtD
Ropivacaine—CYP3A4—Vinorelbine—hematologic cancer	0.0057	0.00991	CbGbCtD
Ropivacaine—CYP2D6—Vinblastine—hematologic cancer	0.00552	0.00961	CbGbCtD
Ropivacaine—CYP3A4—Triamcinolone—hematologic cancer	0.00521	0.00907	CbGbCtD
Ropivacaine—CYP3A4—Dasatinib—hematologic cancer	0.00508	0.00884	CbGbCtD
Ropivacaine—CYP3A4—Mitoxantrone—hematologic cancer	0.00501	0.00873	CbGbCtD
Ropivacaine—CYP3A4—Betamethasone—hematologic cancer	0.00447	0.00778	CbGbCtD
Ropivacaine—CYP3A4—Prednisolone—hematologic cancer	0.00441	0.00767	CbGbCtD
Ropivacaine—CYP3A4—Prednisone—hematologic cancer	0.00416	0.00725	CbGbCtD
Ropivacaine—CYP2D6—Dexamethasone—hematologic cancer	0.00409	0.00712	CbGbCtD
Ropivacaine—CYP3A4—Irinotecan—hematologic cancer	0.00395	0.00687	CbGbCtD
Ropivacaine—CYP3A4—Vinblastine—hematologic cancer	0.00351	0.00611	CbGbCtD
Ropivacaine—CYP3A4—Vincristine—hematologic cancer	0.00345	0.00601	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—hematologic cancer	0.00339	0.0059	CbGbCtD
Ropivacaine—CYP3A4—Etoposide—hematologic cancer	0.00316	0.0055	CbGbCtD
Ropivacaine—CYP3A4—Dexamethasone—hematologic cancer	0.0026	0.00452	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—hematologic cancer	0.00216	0.00375	CbGbCtD
Ropivacaine—SCN2A—hematopoietic system—hematologic cancer	0.00171	0.0661	CbGeAlD
Ropivacaine—SCN10A—hematopoietic system—hematologic cancer	0.00165	0.0637	CbGeAlD
Ropivacaine—SCN8A—testis—hematologic cancer	0.00135	0.0522	CbGeAlD
Ropivacaine—SCN9A—lung—hematologic cancer	0.00126	0.0486	CbGeAlD
Ropivacaine—SCN9A—testis—hematologic cancer	0.00119	0.0459	CbGeAlD
Ropivacaine—SCN2A—blood—hematologic cancer	0.00113	0.0438	CbGeAlD
Ropivacaine—SCN10A—blood—hematologic cancer	0.00109	0.0422	CbGeAlD
Ropivacaine—SCN1A—lung—hematologic cancer	0.00108	0.0418	CbGeAlD
Ropivacaine—SCN4A—testis—hematologic cancer	0.00106	0.0409	CbGeAlD
Ropivacaine—SCN3A—blood—hematologic cancer	0.000995	0.0385	CbGeAlD
Ropivacaine—SCN5A—blood—hematologic cancer	0.000993	0.0384	CbGeAlD
Ropivacaine—SCN3A—bone marrow—hematologic cancer	0.000963	0.0372	CbGeAlD
Ropivacaine—SCN10A—lung—hematologic cancer	0.000957	0.037	CbGeAlD
Ropivacaine—SCN3A—lung—hematologic cancer	0.000873	0.0337	CbGeAlD
Ropivacaine—SCN9A—lymph node—hematologic cancer	0.00086	0.0332	CbGeAlD
Ropivacaine—SCN3A—testis—hematologic cancer	0.000823	0.0318	CbGeAlD
Ropivacaine—CYP1A2—hematopoietic system—hematologic cancer	0.000789	0.0305	CbGeAlD
Ropivacaine—CYP2B6—hematopoietic system—hematologic cancer	0.000756	0.0292	CbGeAlD
Ropivacaine—SCN10A—lymph node—hematologic cancer	0.000655	0.0253	CbGeAlD
Ropivacaine—SCN3A—lymph node—hematologic cancer	0.000597	0.0231	CbGeAlD
Ropivacaine—CYP2B6—gonad—hematologic cancer	0.000575	0.0222	CbGeAlD
Ropivacaine—CYP3A4—hematopoietic system—hematologic cancer	0.000571	0.0221	CbGeAlD
Ropivacaine—CYP2D6—hematopoietic system—hematologic cancer	0.000562	0.0217	CbGeAlD
Ropivacaine—CYP1A2—blood—hematologic cancer	0.000523	0.0202	CbGeAlD
Ropivacaine—CYP2B6—blood—hematologic cancer	0.000501	0.0194	CbGeAlD
Ropivacaine—CYP1A2—lung—hematologic cancer	0.000458	0.0177	CbGeAlD
Ropivacaine—CYP2B6—lung—hematologic cancer	0.000439	0.017	CbGeAlD
Ropivacaine—CYP2B6—testis—hematologic cancer	0.000414	0.016	CbGeAlD
Ropivacaine—CYP3A4—blood—hematologic cancer	0.000378	0.0146	CbGeAlD
Ropivacaine—CYP2D6—blood—hematologic cancer	0.000372	0.0144	CbGeAlD
Ropivacaine—CYP2D6—testis—hematologic cancer	0.000308	0.0119	CbGeAlD
Ropivacaine—Hypersensitivity—Prednisolone—hematologic cancer	2.91e-05	9.4e-05	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—hematologic cancer	2.91e-05	9.39e-05	CcSEcCtD
Ropivacaine—Dyspepsia—Dexamethasone—hematologic cancer	2.91e-05	9.37e-05	CcSEcCtD
Ropivacaine—Dyspepsia—Betamethasone—hematologic cancer	2.91e-05	9.37e-05	CcSEcCtD
Ropivacaine—Urinary tract disorder—Doxorubicin—hematologic cancer	2.89e-05	9.32e-05	CcSEcCtD
Ropivacaine—Urticaria—Triamcinolone—hematologic cancer	2.89e-05	9.32e-05	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—hematologic cancer	2.88e-05	9.3e-05	CcSEcCtD
Ropivacaine—Asthenia—Etoposide—hematologic cancer	2.88e-05	9.28e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Triamcinolone—hematologic cancer	2.88e-05	9.27e-05	CcSEcCtD
Ropivacaine—Anaphylactic shock—Prednisone—hematologic cancer	2.88e-05	9.27e-05	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—hematologic cancer	2.87e-05	9.26e-05	CcSEcCtD
Ropivacaine—Nausea—Irinotecan—hematologic cancer	2.86e-05	9.24e-05	CcSEcCtD
Ropivacaine—Nausea—Mitoxantrone—hematologic cancer	2.86e-05	9.24e-05	CcSEcCtD
Ropivacaine—Infection—Prednisone—hematologic cancer	2.86e-05	9.21e-05	CcSEcCtD
Ropivacaine—Back pain—Methotrexate—hematologic cancer	2.85e-05	9.18e-05	CcSEcCtD
Ropivacaine—Chills—Epirubicin—hematologic cancer	2.84e-05	9.16e-05	CcSEcCtD
Ropivacaine—Pruritus—Etoposide—hematologic cancer	2.84e-05	9.15e-05	CcSEcCtD
Ropivacaine—Shock—Prednisone—hematologic cancer	2.83e-05	9.12e-05	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—hematologic cancer	2.83e-05	9.12e-05	CcSEcCtD
Ropivacaine—Pain—Betamethasone—hematologic cancer	2.82e-05	9.1e-05	CcSEcCtD
Ropivacaine—Pain—Dexamethasone—hematologic cancer	2.82e-05	9.1e-05	CcSEcCtD
Ropivacaine—Tachycardia—Prednisone—hematologic cancer	2.81e-05	9.05e-05	CcSEcCtD
Ropivacaine—Skin disorder—Prednisone—hematologic cancer	2.79e-05	9e-05	CcSEcCtD
Ropivacaine—Nausea—Gemcitabine—hematologic cancer	2.79e-05	9e-05	CcSEcCtD
Ropivacaine—Vomiting—Cisplatin—hematologic cancer	2.78e-05	8.98e-05	CcSEcCtD
Ropivacaine—Hyperhidrosis—Prednisone—hematologic cancer	2.78e-05	8.96e-05	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—hematologic cancer	2.77e-05	8.95e-05	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—hematologic cancer	2.77e-05	8.94e-05	CcSEcCtD
Ropivacaine—Rash—Cisplatin—hematologic cancer	2.76e-05	8.9e-05	CcSEcCtD
Ropivacaine—Dermatitis—Cisplatin—hematologic cancer	2.76e-05	8.89e-05	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—hematologic cancer	2.76e-05	8.88e-05	CcSEcCtD
Ropivacaine—Diarrhoea—Etoposide—hematologic cancer	2.74e-05	8.85e-05	CcSEcCtD
Ropivacaine—Ill-defined disorder—Methotrexate—hematologic cancer	2.73e-05	8.81e-05	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—hematologic cancer	2.73e-05	8.8e-05	CcSEcCtD
Ropivacaine—Anaemia—Methotrexate—hematologic cancer	2.72e-05	8.77e-05	CcSEcCtD
Ropivacaine—Feeling abnormal—Dexamethasone—hematologic cancer	2.72e-05	8.77e-05	CcSEcCtD
Ropivacaine—Feeling abnormal—Betamethasone—hematologic cancer	2.72e-05	8.77e-05	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—hematologic cancer	2.72e-05	8.76e-05	CcSEcCtD
Ropivacaine—Tension—Epirubicin—hematologic cancer	2.7e-05	8.72e-05	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.7e-05	8.7e-05	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.7e-05	8.7e-05	CcSEcCtD
Ropivacaine—Hypersensitivity—Triamcinolone—hematologic cancer	2.68e-05	8.64e-05	CcSEcCtD
Ropivacaine—Nervousness—Epirubicin—hematologic cancer	2.68e-05	8.63e-05	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—hematologic cancer	2.67e-05	8.59e-05	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—hematologic cancer	2.65e-05	8.56e-05	CcSEcCtD
Ropivacaine—Dizziness—Etoposide—hematologic cancer	2.65e-05	8.55e-05	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—hematologic cancer	2.65e-05	8.54e-05	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—hematologic cancer	2.65e-05	8.53e-05	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—hematologic cancer	2.63e-05	8.47e-05	CcSEcCtD
Ropivacaine—Urticaria—Dexamethasone—hematologic cancer	2.62e-05	8.46e-05	CcSEcCtD
Ropivacaine—Urticaria—Betamethasone—hematologic cancer	2.62e-05	8.46e-05	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.62e-05	8.45e-05	CcSEcCtD
Ropivacaine—Dizziness—Prednisolone—hematologic cancer	2.62e-05	8.44e-05	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—hematologic cancer	2.62e-05	8.43e-05	CcSEcCtD
Ropivacaine—Asthenia—Triamcinolone—hematologic cancer	2.61e-05	8.42e-05	CcSEcCtD
Ropivacaine—Abdominal pain—Dexamethasone—hematologic cancer	2.61e-05	8.41e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Betamethasone—hematologic cancer	2.61e-05	8.41e-05	CcSEcCtD
Ropivacaine—Abdominal pain—Betamethasone—hematologic cancer	2.61e-05	8.41e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Dexamethasone—hematologic cancer	2.61e-05	8.41e-05	CcSEcCtD
Ropivacaine—Nausea—Cisplatin—hematologic cancer	2.6e-05	8.39e-05	CcSEcCtD
Ropivacaine—Insomnia—Prednisone—hematologic cancer	2.6e-05	8.38e-05	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—hematologic cancer	2.6e-05	8.37e-05	CcSEcCtD
Ropivacaine—Paraesthesia—Prednisone—hematologic cancer	2.58e-05	8.32e-05	CcSEcCtD
Ropivacaine—Pruritus—Triamcinolone—hematologic cancer	2.57e-05	8.3e-05	CcSEcCtD
Ropivacaine—Cough—Methotrexate—hematologic cancer	2.57e-05	8.28e-05	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—hematologic cancer	2.57e-05	8.27e-05	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—hematologic cancer	2.56e-05	8.24e-05	CcSEcCtD
Ropivacaine—Convulsion—Methotrexate—hematologic cancer	2.55e-05	8.22e-05	CcSEcCtD
Ropivacaine—Vomiting—Etoposide—hematologic cancer	2.55e-05	8.22e-05	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—hematologic cancer	2.55e-05	8.22e-05	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—hematologic cancer	2.55e-05	8.21e-05	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—hematologic cancer	2.53e-05	8.16e-05	CcSEcCtD
Ropivacaine—Dyspepsia—Prednisone—hematologic cancer	2.53e-05	8.16e-05	CcSEcCtD
Ropivacaine—Rash—Etoposide—hematologic cancer	2.53e-05	8.15e-05	CcSEcCtD
Ropivacaine—Dermatitis—Etoposide—hematologic cancer	2.53e-05	8.15e-05	CcSEcCtD
Ropivacaine—Headache—Etoposide—hematologic cancer	2.51e-05	8.1e-05	CcSEcCtD
Ropivacaine—Myalgia—Methotrexate—hematologic cancer	2.51e-05	8.08e-05	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—hematologic cancer	2.51e-05	8.08e-05	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—hematologic cancer	2.51e-05	8.08e-05	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—hematologic cancer	2.5e-05	8.07e-05	CcSEcCtD
Ropivacaine—Rash—Prednisolone—hematologic cancer	2.49e-05	8.04e-05	CcSEcCtD
Ropivacaine—Dermatitis—Prednisolone—hematologic cancer	2.49e-05	8.04e-05	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—hematologic cancer	2.48e-05	8.01e-05	CcSEcCtD
Ropivacaine—Headache—Prednisolone—hematologic cancer	2.48e-05	7.99e-05	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—hematologic cancer	2.48e-05	7.98e-05	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—hematologic cancer	2.48e-05	7.98e-05	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—hematologic cancer	2.48e-05	7.98e-05	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—hematologic cancer	2.47e-05	7.97e-05	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—hematologic cancer	2.47e-05	7.95e-05	CcSEcCtD
Ropivacaine—Constipation—Prednisone—hematologic cancer	2.46e-05	7.93e-05	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—hematologic cancer	2.45e-05	7.9e-05	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—hematologic cancer	2.42e-05	7.81e-05	CcSEcCtD
Ropivacaine—Loss of consciousness—Epirubicin—hematologic cancer	2.42e-05	7.81e-05	CcSEcCtD
Ropivacaine—Dizziness—Triamcinolone—hematologic cancer	2.41e-05	7.76e-05	CcSEcCtD
Ropivacaine—Cough—Epirubicin—hematologic cancer	2.4e-05	7.75e-05	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—hematologic cancer	2.4e-05	7.75e-05	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—hematologic cancer	2.4e-05	7.75e-05	CcSEcCtD
Ropivacaine—Convulsion—Epirubicin—hematologic cancer	2.39e-05	7.7e-05	CcSEcCtD
Ropivacaine—Infection—Methotrexate—hematologic cancer	2.39e-05	7.7e-05	CcSEcCtD
Ropivacaine—Nausea—Etoposide—hematologic cancer	2.38e-05	7.68e-05	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—hematologic cancer	2.38e-05	7.67e-05	CcSEcCtD
Ropivacaine—Feeling abnormal—Prednisone—hematologic cancer	2.37e-05	7.64e-05	CcSEcCtD
Ropivacaine—Asthenia—Betamethasone—hematologic cancer	2.37e-05	7.64e-05	CcSEcCtD
Ropivacaine—Asthenia—Dexamethasone—hematologic cancer	2.37e-05	7.64e-05	CcSEcCtD
Ropivacaine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.37e-05	7.63e-05	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—hematologic cancer	2.36e-05	7.6e-05	CcSEcCtD
Ropivacaine—Thrombocytopenia—Methotrexate—hematologic cancer	2.35e-05	7.58e-05	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Prednisone—hematologic cancer	2.35e-05	7.58e-05	CcSEcCtD
Ropivacaine—Nausea—Prednisolone—hematologic cancer	2.35e-05	7.58e-05	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—hematologic cancer	2.35e-05	7.56e-05	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—hematologic cancer	2.35e-05	7.56e-05	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—hematologic cancer	2.35e-05	7.56e-05	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—hematologic cancer	2.34e-05	7.55e-05	CcSEcCtD
Ropivacaine—Anxiety—Epirubicin—hematologic cancer	2.34e-05	7.54e-05	CcSEcCtD
Ropivacaine—Pruritus—Dexamethasone—hematologic cancer	2.34e-05	7.53e-05	CcSEcCtD
Ropivacaine—Pruritus—Betamethasone—hematologic cancer	2.34e-05	7.53e-05	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—hematologic cancer	2.33e-05	7.52e-05	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—hematologic cancer	2.32e-05	7.49e-05	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—hematologic cancer	2.32e-05	7.47e-05	CcSEcCtD
Ropivacaine—Vomiting—Triamcinolone—hematologic cancer	2.31e-05	7.46e-05	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—hematologic cancer	2.3e-05	7.41e-05	CcSEcCtD
Ropivacaine—Rash—Triamcinolone—hematologic cancer	2.29e-05	7.4e-05	CcSEcCtD
Ropivacaine—Dermatitis—Triamcinolone—hematologic cancer	2.29e-05	7.39e-05	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—hematologic cancer	2.29e-05	7.38e-05	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—hematologic cancer	2.29e-05	7.37e-05	CcSEcCtD
Ropivacaine—Urticaria—Prednisone—hematologic cancer	2.28e-05	7.36e-05	CcSEcCtD
Ropivacaine—Headache—Triamcinolone—hematologic cancer	2.28e-05	7.35e-05	CcSEcCtD
Ropivacaine—Abdominal pain—Prednisone—hematologic cancer	2.27e-05	7.33e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Prednisone—hematologic cancer	2.27e-05	7.33e-05	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—hematologic cancer	2.27e-05	7.31e-05	CcSEcCtD
Ropivacaine—Diarrhoea—Betamethasone—hematologic cancer	2.26e-05	7.28e-05	CcSEcCtD
Ropivacaine—Diarrhoea—Dexamethasone—hematologic cancer	2.26e-05	7.28e-05	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—hematologic cancer	2.25e-05	7.25e-05	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—hematologic cancer	2.25e-05	7.24e-05	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—hematologic cancer	2.24e-05	7.22e-05	CcSEcCtD
Ropivacaine—Infection—Epirubicin—hematologic cancer	2.23e-05	7.2e-05	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—hematologic cancer	2.22e-05	7.17e-05	CcSEcCtD
Ropivacaine—Shock—Epirubicin—hematologic cancer	2.21e-05	7.13e-05	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—hematologic cancer	2.21e-05	7.12e-05	CcSEcCtD
Ropivacaine—Thrombocytopenia—Epirubicin—hematologic cancer	2.2e-05	7.1e-05	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—hematologic cancer	2.2e-05	7.1e-05	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—hematologic cancer	2.19e-05	7.08e-05	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.19e-05	7.06e-05	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—hematologic cancer	2.18e-05	7.04e-05	CcSEcCtD
Ropivacaine—Dizziness—Dexamethasone—hematologic cancer	2.18e-05	7.04e-05	CcSEcCtD
Ropivacaine—Dizziness—Betamethasone—hematologic cancer	2.18e-05	7.04e-05	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—hematologic cancer	2.17e-05	7.01e-05	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—hematologic cancer	2.17e-05	7.01e-05	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—hematologic cancer	2.17e-05	7e-05	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—hematologic cancer	2.17e-05	7e-05	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—hematologic cancer	2.17e-05	7e-05	CcSEcCtD
Ropivacaine—Anxiety—Doxorubicin—hematologic cancer	2.16e-05	6.97e-05	CcSEcCtD
Ropivacaine—Nausea—Triamcinolone—hematologic cancer	2.16e-05	6.97e-05	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—hematologic cancer	2.16e-05	6.96e-05	CcSEcCtD
Ropivacaine—Discomfort—Doxorubicin—hematologic cancer	2.14e-05	6.91e-05	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—hematologic cancer	2.14e-05	6.91e-05	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—hematologic cancer	2.14e-05	6.89e-05	CcSEcCtD
Ropivacaine—Hypersensitivity—Prednisone—hematologic cancer	2.12e-05	6.83e-05	CcSEcCtD
Ropivacaine—Dyspepsia—Methotrexate—hematologic cancer	2.12e-05	6.82e-05	CcSEcCtD
Ropivacaine—Hypotension—Epirubicin—hematologic cancer	2.1e-05	6.77e-05	CcSEcCtD
Ropivacaine—Vomiting—Dexamethasone—hematologic cancer	2.1e-05	6.77e-05	CcSEcCtD
Ropivacaine—Vomiting—Betamethasone—hematologic cancer	2.1e-05	6.77e-05	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—hematologic cancer	2.1e-05	6.76e-05	CcSEcCtD
Ropivacaine—Rash—Dexamethasone—hematologic cancer	2.08e-05	6.71e-05	CcSEcCtD
Ropivacaine—Rash—Betamethasone—hematologic cancer	2.08e-05	6.71e-05	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.08e-05	6.71e-05	CcSEcCtD
Ropivacaine—Dermatitis—Dexamethasone—hematologic cancer	2.08e-05	6.71e-05	CcSEcCtD
Ropivacaine—Dermatitis—Betamethasone—hematologic cancer	2.08e-05	6.71e-05	CcSEcCtD
Ropivacaine—Headache—Dexamethasone—hematologic cancer	2.07e-05	6.67e-05	CcSEcCtD
Ropivacaine—Headache—Betamethasone—hematologic cancer	2.07e-05	6.67e-05	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—hematologic cancer	2.07e-05	6.66e-05	CcSEcCtD
Ropivacaine—Asthenia—Prednisone—hematologic cancer	2.06e-05	6.65e-05	CcSEcCtD
Ropivacaine—Pain—Methotrexate—hematologic cancer	2.05e-05	6.62e-05	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.05e-05	6.61e-05	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—hematologic cancer	2.05e-05	6.6e-05	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.04e-05	6.57e-05	CcSEcCtD
Ropivacaine—Pruritus—Prednisone—hematologic cancer	2.03e-05	6.56e-05	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—hematologic cancer	2.03e-05	6.56e-05	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—hematologic cancer	2.03e-05	6.55e-05	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—hematologic cancer	2.02e-05	6.52e-05	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—hematologic cancer	2.02e-05	6.51e-05	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.01e-05	6.48e-05	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—hematologic cancer	2e-05	6.46e-05	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—hematologic cancer	2e-05	6.45e-05	CcSEcCtD
Ropivacaine—Feeling abnormal—Methotrexate—hematologic cancer	1.98e-05	6.38e-05	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—hematologic cancer	1.98e-05	6.38e-05	CcSEcCtD
Ropivacaine—Diarrhoea—Prednisone—hematologic cancer	1.97e-05	6.34e-05	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.96e-05	6.33e-05	CcSEcCtD
Ropivacaine—Nausea—Dexamethasone—hematologic cancer	1.96e-05	6.32e-05	CcSEcCtD
Ropivacaine—Nausea—Betamethasone—hematologic cancer	1.96e-05	6.32e-05	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—hematologic cancer	1.94e-05	6.27e-05	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—hematologic cancer	1.92e-05	6.2e-05	CcSEcCtD
Ropivacaine—Pain—Epirubicin—hematologic cancer	1.92e-05	6.2e-05	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—hematologic cancer	1.91e-05	6.15e-05	CcSEcCtD
Ropivacaine—Dizziness—Prednisone—hematologic cancer	1.9e-05	6.13e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—hematologic cancer	1.9e-05	6.12e-05	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—hematologic cancer	1.9e-05	6.12e-05	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.9e-05	6.11e-05	CcSEcCtD
Ropivacaine—Insomnia—Doxorubicin—hematologic cancer	1.88e-05	6.07e-05	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—hematologic cancer	1.87e-05	6.02e-05	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—hematologic cancer	1.85e-05	5.98e-05	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—hematologic cancer	1.85e-05	5.97e-05	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—hematologic cancer	1.85e-05	5.96e-05	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.84e-05	5.93e-05	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—hematologic cancer	1.83e-05	5.9e-05	CcSEcCtD
Ropivacaine—Vomiting—Prednisone—hematologic cancer	1.83e-05	5.89e-05	CcSEcCtD
Ropivacaine—Rash—Prednisone—hematologic cancer	1.81e-05	5.84e-05	CcSEcCtD
Ropivacaine—Dermatitis—Prednisone—hematologic cancer	1.81e-05	5.84e-05	CcSEcCtD
Ropivacaine—Headache—Prednisone—hematologic cancer	1.8e-05	5.81e-05	CcSEcCtD
Ropivacaine—Urticaria—Epirubicin—hematologic cancer	1.79e-05	5.76e-05	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—hematologic cancer	1.78e-05	5.74e-05	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—hematologic cancer	1.78e-05	5.74e-05	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—hematologic cancer	1.78e-05	5.73e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—hematologic cancer	1.78e-05	5.73e-05	CcSEcCtD
Ropivacaine—Hypersensitivity—Methotrexate—hematologic cancer	1.77e-05	5.71e-05	CcSEcCtD
Ropivacaine—Asthenia—Methotrexate—hematologic cancer	1.72e-05	5.56e-05	CcSEcCtD
Ropivacaine—Feeling abnormal—Doxorubicin—hematologic cancer	1.71e-05	5.53e-05	CcSEcCtD
Ropivacaine—Nausea—Prednisone—hematologic cancer	1.71e-05	5.51e-05	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.7e-05	5.49e-05	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—hematologic cancer	1.7e-05	5.48e-05	CcSEcCtD
Ropivacaine—Hypersensitivity—Epirubicin—hematologic cancer	1.66e-05	5.34e-05	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—hematologic cancer	1.65e-05	5.33e-05	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—hematologic cancer	1.64e-05	5.3e-05	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—hematologic cancer	1.64e-05	5.3e-05	CcSEcCtD
Ropivacaine—Diarrhoea—Methotrexate—hematologic cancer	1.64e-05	5.3e-05	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—hematologic cancer	1.61e-05	5.2e-05	CcSEcCtD
Ropivacaine—Pruritus—Epirubicin—hematologic cancer	1.59e-05	5.13e-05	CcSEcCtD
Ropivacaine—Dizziness—Methotrexate—hematologic cancer	1.59e-05	5.12e-05	CcSEcCtD
Ropivacaine—Diarrhoea—Epirubicin—hematologic cancer	1.54e-05	4.96e-05	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—hematologic cancer	1.53e-05	4.94e-05	CcSEcCtD
Ropivacaine—Vomiting—Methotrexate—hematologic cancer	1.53e-05	4.93e-05	CcSEcCtD
Ropivacaine—Rash—Methotrexate—hematologic cancer	1.51e-05	4.88e-05	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—hematologic cancer	1.51e-05	4.88e-05	CcSEcCtD
Ropivacaine—Headache—Methotrexate—hematologic cancer	1.51e-05	4.85e-05	CcSEcCtD
Ropivacaine—Asthenia—Doxorubicin—hematologic cancer	1.49e-05	4.81e-05	CcSEcCtD
Ropivacaine—Dizziness—Epirubicin—hematologic cancer	1.49e-05	4.79e-05	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—hematologic cancer	1.47e-05	4.75e-05	CcSEcCtD
Ropivacaine—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.46e-05	0.000164	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.46e-05	0.000163	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.46e-05	0.000163	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HDC—hematologic cancer	1.43e-05	0.00016	CbGpPWpGaD
Ropivacaine—Vomiting—Epirubicin—hematologic cancer	1.43e-05	4.61e-05	CcSEcCtD
Ropivacaine—Nausea—Methotrexate—hematologic cancer	1.43e-05	4.6e-05	CcSEcCtD
Ropivacaine—CYP2B6—Metabolism—FHL2—hematologic cancer	1.43e-05	0.00016	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—hematologic cancer	1.43e-05	0.00016	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—hematologic cancer	1.43e-05	0.00016	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—SRC—hematologic cancer	1.43e-05	0.00016	CbGpPWpGaD
Ropivacaine—Diarrhoea—Doxorubicin—hematologic cancer	1.42e-05	4.59e-05	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—AKT1—hematologic cancer	1.42e-05	0.000159	CbGpPWpGaD
Ropivacaine—Rash—Epirubicin—hematologic cancer	1.42e-05	4.57e-05	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—hematologic cancer	1.42e-05	4.57e-05	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—IL6—hematologic cancer	1.42e-05	0.000159	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—hematologic cancer	1.42e-05	0.000159	CbGpPWpGaD
Ropivacaine—Headache—Epirubicin—hematologic cancer	1.41e-05	4.54e-05	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—HRAS—hematologic cancer	1.41e-05	0.000157	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AGRN—hematologic cancer	1.4e-05	0.000157	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—hematologic cancer	1.39e-05	0.000155	CbGpPWpGaD
Ropivacaine—Dizziness—Doxorubicin—hematologic cancer	1.38e-05	4.44e-05	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—STAT3—hematologic cancer	1.37e-05	0.000154	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—hematologic cancer	1.37e-05	0.000153	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—hematologic cancer	1.37e-05	0.000153	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—hematologic cancer	1.37e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.36e-05	0.000153	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—hematologic cancer	1.36e-05	0.000152	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—hematologic cancer	1.35e-05	0.000151	CbGpPWpGaD
Ropivacaine—Nausea—Epirubicin—hematologic cancer	1.34e-05	4.31e-05	CcSEcCtD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.33e-05	0.000149	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMMR—hematologic cancer	1.33e-05	0.000148	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—IDH2—hematologic cancer	1.33e-05	0.000148	CbGpPWpGaD
Ropivacaine—Vomiting—Doxorubicin—hematologic cancer	1.32e-05	4.27e-05	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—MAPK3—hematologic cancer	1.31e-05	0.000147	CbGpPWpGaD
Ropivacaine—Rash—Doxorubicin—hematologic cancer	1.31e-05	4.23e-05	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—hematologic cancer	1.31e-05	4.23e-05	CcSEcCtD
Ropivacaine—CYP2D6—Metabolism—CDA—hematologic cancer	1.31e-05	0.000146	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—hematologic cancer	1.31e-05	0.000146	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—hematologic cancer	1.31e-05	0.000146	CbGpPWpGaD
Ropivacaine—Headache—Doxorubicin—hematologic cancer	1.3e-05	4.2e-05	CcSEcCtD
Ropivacaine—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.28e-05	0.000143	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ASNS—hematologic cancer	1.28e-05	0.000143	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DCK—hematologic cancer	1.28e-05	0.000143	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—hematologic cancer	1.27e-05	0.000143	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—hematologic cancer	1.26e-05	0.000141	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—hematologic cancer	1.26e-05	0.000141	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PC—hematologic cancer	1.26e-05	0.000141	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.25e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ARNTL—hematologic cancer	1.25e-05	0.00014	CbGpPWpGaD
Ropivacaine—Nausea—Doxorubicin—hematologic cancer	1.24e-05	3.98e-05	CcSEcCtD
Ropivacaine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.23e-05	0.000138	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.23e-05	0.000138	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.23e-05	0.000138	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.22e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GBA—hematologic cancer	1.22e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CA9—hematologic cancer	1.21e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ACP5—hematologic cancer	1.21e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HDC—hematologic cancer	1.21e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NCOR2—hematologic cancer	1.2e-05	0.000134	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—hematologic cancer	1.19e-05	0.000133	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—hematologic cancer	1.18e-05	0.000132	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—IDH1—hematologic cancer	1.14e-05	0.000128	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.13e-05	0.000127	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.13e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCC3—hematologic cancer	1.13e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TXN—hematologic cancer	1.13e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTO1—hematologic cancer	1.13e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.11e-05	0.000125	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CDA—hematologic cancer	1.11e-05	0.000124	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SPHK1—hematologic cancer	1.1e-05	0.000124	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PC—hematologic cancer	1.07e-05	0.000119	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—UGT1A1—hematologic cancer	1.06e-05	0.000119	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC22A1—hematologic cancer	1.03e-05	0.000115	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CRABP1—hematologic cancer	1.03e-05	0.000115	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.03e-05	0.000115	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GBA—hematologic cancer	1.03e-05	0.000115	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALOX5—hematologic cancer	1.01e-05	0.000113	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—hematologic cancer	1e-05	0.000112	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—FHL2—hematologic cancer	9.92e-06	0.000111	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.87e-06	0.00011	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DCK—hematologic cancer	9.87e-06	0.00011	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ASNS—hematologic cancer	9.87e-06	0.00011	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NUP98—hematologic cancer	9.74e-06	0.000109	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AGRN—hematologic cancer	9.73e-06	0.000109	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—hematologic cancer	9.6e-06	0.000107	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADCY7—hematologic cancer	9.45e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NCOA3—hematologic cancer	9.45e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTAP—hematologic cancer	9.43e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NUP214—hematologic cancer	9.39e-06	0.000105	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HDC—hematologic cancer	9.36e-06	0.000105	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMMR—hematologic cancer	9.22e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—IDH2—hematologic cancer	9.22e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCG2—hematologic cancer	9.2e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTR—hematologic cancer	9.2e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—hematologic cancer	9.02e-06	0.000101	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—hematologic cancer	8.86e-06	9.91e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTT1—hematologic cancer	8.75e-06	9.79e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ARNTL—hematologic cancer	8.67e-06	9.7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CDA—hematologic cancer	8.56e-06	9.58e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SDC1—hematologic cancer	8.55e-06	9.57e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CA9—hematologic cancer	8.43e-06	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ACP5—hematologic cancer	8.43e-06	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—FHL2—hematologic cancer	8.4e-06	9.4e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NCOR2—hematologic cancer	8.32e-06	9.32e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AGRN—hematologic cancer	8.24e-06	9.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PC—hematologic cancer	8.24e-06	9.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GBA—hematologic cancer	7.95e-06	8.9e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.95e-06	8.9e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—IDH1—hematologic cancer	7.93e-06	8.88e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCC3—hematologic cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TXN—hematologic cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTO1—hematologic cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMMR—hematologic cancer	7.81e-06	8.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—IDH2—hematologic cancer	7.81e-06	8.74e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SPHK1—hematologic cancer	7.67e-06	8.59e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.37e-06	8.25e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.37e-06	8.24e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ARNTL—hematologic cancer	7.34e-06	8.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.28e-06	8.14e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NQO1—hematologic cancer	7.27e-06	8.14e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CD44—hematologic cancer	7.27e-06	8.14e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.17e-06	8.03e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.17e-06	8.03e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CA9—hematologic cancer	7.14e-06	8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ACP5—hematologic cancer	7.14e-06	8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.05e-06	7.89e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.99e-06	7.82e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYCS—hematologic cancer	6.88e-06	7.7e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	6.83e-06	7.65e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NUP98—hematologic cancer	6.77e-06	7.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—IDH1—hematologic cancer	6.72e-06	7.52e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.64e-06	7.43e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TXN—hematologic cancer	6.64e-06	7.43e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.64e-06	7.43e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.57e-06	7.35e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.57e-06	7.35e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NUP214—hematologic cancer	6.52e-06	7.3e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.5e-06	7.28e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FHL2—hematologic cancer	6.48e-06	7.26e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.39e-06	7.15e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTR—hematologic cancer	6.39e-06	7.15e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.36e-06	7.12e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.27e-06	7.02e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.24e-06	6.99e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.08e-06	6.8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.07e-06	6.8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.07e-06	6.8e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—hematologic cancer	6.06e-06	6.79e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.03e-06	6.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.03e-06	6.75e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.94e-06	6.65e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.92e-06	6.63e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCB1—hematologic cancer	5.74e-06	6.42e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NUP98—hematologic cancer	5.73e-06	6.42e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.67e-06	6.34e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—hematologic cancer	5.57e-06	6.24e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NCOR1—hematologic cancer	5.57e-06	6.24e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.57e-06	6.23e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.57e-06	6.23e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NUP214—hematologic cancer	5.53e-06	6.19e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CA9—hematologic cancer	5.51e-06	6.17e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.51e-06	6.17e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.47e-06	6.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.44e-06	6.09e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.41e-06	6.06e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTR—hematologic cancer	5.41e-06	6.06e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—hematologic cancer	5.31e-06	5.94e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.18e-06	5.8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.15e-06	5.76e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TXN—hematologic cancer	5.13e-06	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.13e-06	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.13e-06	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.07e-06	5.68e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NQO1—hematologic cancer	5.05e-06	5.65e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CD44—hematologic cancer	5.05e-06	5.65e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SDC1—hematologic cancer	5.03e-06	5.63e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.02e-06	5.61e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—hematologic cancer	4.92e-06	5.51e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.82e-06	5.39e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.81e-06	5.38e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.78e-06	5.35e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.75e-06	5.32e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.75e-06	5.31e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.69e-06	5.25e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.69e-06	5.25e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.57e-06	5.11e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.54e-06	5.08e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.42e-06	4.95e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.3e-06	4.81e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.3e-06	4.81e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CD44—hematologic cancer	4.28e-06	4.79e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NQO1—hematologic cancer	4.28e-06	4.79e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.27e-06	4.77e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.21e-06	4.72e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.19e-06	4.69e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.18e-06	4.68e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTR—hematologic cancer	4.18e-06	4.68e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	4.14e-06	4.63e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.1e-06	4.59e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYCS—hematologic cancer	4.05e-06	4.53e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.02e-06	4.5e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.99e-06	4.46e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.97e-06	4.45e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.88e-06	4.35e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.87e-06	4.33e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.87e-06	4.33e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CREBBP—hematologic cancer	3.84e-06	4.29e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	3.64e-06	4.07e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.62e-06	4.05e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—hematologic cancer	3.59e-06	4.02e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.57e-06	4e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.45e-06	3.87e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.43e-06	3.84e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.42e-06	3.83e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.38e-06	3.78e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CD44—hematologic cancer	3.3e-06	3.7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.3e-06	3.7e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.28e-06	3.67e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.28e-06	3.67e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.17e-06	3.55e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.13e-06	3.5e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.11e-06	3.48e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.9e-06	3.24e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.88e-06	3.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.76e-06	3.08e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—hematologic cancer	2.74e-06	3.07e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.67e-06	2.98e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—EP300—hematologic cancer	2.61e-06	2.92e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.61e-06	2.92e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.55e-06	2.86e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.53e-06	2.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.53e-06	2.83e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.53e-06	2.83e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—hematologic cancer	2.5e-06	2.79e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.44e-06	2.73e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.39e-06	2.67e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.26e-06	2.53e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.24e-06	2.5e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.2e-06	2.47e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.14e-06	2.4e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—hematologic cancer	2.11e-06	2.37e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.02e-06	2.26e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.93e-06	2.16e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.9e-06	2.13e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.88e-06	2.1e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.87e-06	2.09e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—EP300—hematologic cancer	1.82e-06	2.03e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.74e-06	1.95e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.65e-06	1.85e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—hematologic cancer	1.63e-06	1.83e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.61e-06	1.81e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.58e-06	1.77e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.56e-06	1.75e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—EP300—hematologic cancer	1.54e-06	1.72e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.44e-06	1.61e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.34e-06	1.5e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.24e-06	1.39e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—EP300—hematologic cancer	1.19e-06	1.33e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.27e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—hematologic cancer	9.3e-07	1.04e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.78e-07	9.83e-06	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.17e-07	8.03e-06	CbGpPWpGaD
